FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
 OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                       
1. Name and Address of Reporting Person * Ranade Mandar 2. Issuer Name and Ticker or Trading Symbol KEWAUNEE SCIENTIFIC CORP /DE/ [ KEQU ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
VP-Information Technology
(Last)         (First)         (Middle)
2700 WEST FRONT STREET		 3. Date of Earliest Transaction (MM/DD/YYYY)
6/19/2020
(Street)
STATESVILLE, NC 28677
(City)       (State)       (Zip)
 4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
 6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  6/19/2020    M    208  A $0 (1) 208  D   
Common Stock  6/19/2020    F    65  D $9.67  143  D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units   (1) 6/19/2020    M        208    (2)  (2) Common Stock  208.0  $0  3039  D   

Explanation of Responses:
(1)  Restricted stock units convert to common stock on a one-for-one basis.
(2)  On December 2, 2019, the reporting person was granted restricted stock units that vest as follows: (a) 974 of the restricted stock units subject to the award consist of service-based restricted stock units, 208 of which vest on June 19, 2020, 383 of which vest on June 19, 2021, and 383 of which vest on June 19, 2022, in each case subject to the reporting person's continued employment with the Company; and (b) 2,273 of the restricted stock units subject to the award consist of performance-based restricted stock units that will vest only if performance goals are achieved through June 19, 2022. The actual number of units (if any) received under this award will depend on continued employment and actual performance through June 19, 2022.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Ranade Mandar
2700 WEST FRONT STREET
STATESVILLE, NC 28677

VP-Information Technology

Signatures
/s/ Donald T. Gardner, III, Attorney-in-fact 6/22/2020
**Signature of Reporting Person Date